Stamp LK, et al. - Researchers examined the association of gout and serum urate (SU) with enhanced risk of death, time to first readmission for any cardiovascular event or incident heart failure in people with cardiovascular disease. In the Coronary Disease Cohort Study, clinical data of 1514 acute coronary syndrome (ACS) patients were collected from the index hospital admission, and clinical, echocardiographic, and biochemical data were collected post-discharge. Death was reported for 53/160 (33.1%) of those with gout and 298/1354 (22.1%) of those without gout during the follow-up period. Patients with and without gout had similar survival post-ACS. They noted an increased risk of readmission for heart failure and higher length of stay for people with gout. The increase in the risk of these events was noted in parallel with SU.